Steinberg Global Asset Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Steinberg Global Asset Management’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,356	Closed	-$76K	–	227
2014 Q4	$76K	Sell	1,356 -625	-32%	-$42.7K	0.02%	183
2014 Q3	$143K	Hold	1,981	–	–	0.03%	184
2014 Q2	$297K	Buy	+1,981	New	+$301K	0.07%	157

Other funds holding GNCA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Steinberg Global Asset Management's GNCA Position: Q1 2015 in Review

Steinberg Global Asset Management sold out of Genocea Biosciences, Inc. (GNCA) in Q1 2015, closing a stake of 1,356 shares — an estimated $76K sold.

Steinberg Global Asset Management first reported a position in GNCA in Q2 2014 and held it in 3 quarters. The position peaked at $297K in Q2 2014. 47 funds tracked by Wall St. Rank hold GNCA as of Q1 2015.

Steinberg Global Asset Management reported no remaining Genocea Biosciences, Inc. position as of Q1 2015 after selling out during the quarter.
Steinberg Global Asset Management sold 1,356 Genocea Biosciences, Inc. shares in Q1 2015, an estimated $76K.
Steinberg Global Asset Management first reported a position in Genocea Biosciences, Inc. in Q2 2014 and held it in 3 quarters.
Steinberg Global Asset Management's Genocea Biosciences, Inc. position peaked at $297K in Q2 2014.
47 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q1 2015.

Based on Steinberg Global Asset Management's 13F filing for Q1 2015, filed 15 May 2015.